Boostrix Polio, susp inj 0.5 ml (ancien), ser prê 1 dos

7680006810013 Pharmacode 2819951 CH-681 J07CA02
Boostrix Polio, susp inj 0.5 ml (ancien), ser prê 1 dos
Boostrix Polio, susp inj 0.5 ml (ancien), ser prê 1 dos
Boostrix Polio, susp inj 0.5 ml (ancien), ser prê 1 dos
1 / 3
google

Details

GTIN
7680006810013
Pharmacode
2819951
Product number
-
CPT
-
Packaging group
-
Unit
-

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
26/06/2025
Professional SmPC
Français
26/06/2025
Professional SmPC
Italien
26/06/2025

Detailed composition

Substance Quantity Type Category
toxoidum diphtheriae
- Substance Wirkstoff (Principe actif)
toxoidum tetani
- Substance Wirkstoff (Principe actif)
toxoidum pertussis
8.0 UG Substance Wirkstoff (Principe actif)
haemagglutininum filamentosum
8.0 UG Substance Wirkstoff (Principe actif)
pertactinum
2.5 UG Substance Wirkstoff (Principe actif)
virus poliomyelitis typus 1 inactivatus
40.0 U Substance Wirkstoff (Principe actif)
virus poliomyelitis typus 2 inactivatus
8.0 U Substance Wirkstoff (Principe actif)
virus poliomyelitis typus 3 inactivatus
32.0 U Substance Wirkstoff (Principe actif)
natrii chloridum
- Substance HNIDK
natrium
1.8 MG Substance HBESI
aluminium
0.5 MG Substance HBESI
aluminii hydroxidum hydricum ad adsorptionem
- Substance HNIDK
aluminii phosphas
- Substance HNIDK
medium 199
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
neomycini sulfas
- Substance RESI
polymyxini B sulfas
- Substance RESI
polysorbatum 80
- Substance RESI
formaldehydum
- Substance RESI

Authorization holder

GlaxoSmithKline AG

6340 Baar

Authorization information

Swissmedic authorization number
681
Drug name
Boostrix Polio, Injektionssuspension
Galenic form
SUPA
ATC Code
J07CA02
Authorization status
Z
Dispensation category
B
First authorization
01/04/2004
Authorization expiration date
31/12/9999
IT number
08.08.
Domain
Human medicine
Field of application
aktive Auffrischimpfung gegen Diphtherie, Tetanus, Pertussis und Poliomyelitis, ab dem vollendeten 4. Lebensjahr

Packaging details

Description (FR)
BOOSTRIX Polio susp inj ser pré 0.5 ml
Description (DE)
BOOSTRIX Polio Inj Susp Fertspr 0.5 ml
Narcotic (BTM)
No

Application methods

IMU

Other packaging sizes

BOOSTRIX Polio susp inj (n ser pré) ser pré 0.5 ml
1 FESP
View
BOOSTRIX Polio susp inj (n ser pré) 10 x 0.5 ml
10 FESP
View
Buy us a coffee Explore the data